Verrica Pharmaceuticals (VRCA) Insider Trading & Ownership → Jeff Bezos Just Humiliated Elon Musk (From InvestorPlace) (Ad) Free vrca Stock Alerts $7.31 +0.05 (+0.69%) (As of 05/6/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Verrica Pharmaceuticals (NASDAQ:VRCA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage42.60%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$8.94 MNumber OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$471,200.18 Get VRCA Insider Trade Alerts Want to know when executives and insiders are buying or selling Verrica Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VRCA Insider Buying and Selling by Quarter Ad Behind the MarketsRevealed: The Unknown Biotech Powering AI in HealthcareThe CEO of Google predicted this is "one of the most important things for humanity." We're standing at the brink of an AI revolution in medicine, a leap forward that will change the future medicine as we know it. If you're only watching tech giants like NVIDIA and Google for AI investments, you're missing the biggest opportunities... Because I've uncovered a little known biotech at the heart of this AI medical revolution.To discover the name and ticker of this hidden gem click here>>>> Verrica Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/28/2023Perceptive Advisors LlcMajor ShareholderBuy126,116$7.08$892,901.28 12/26/2023Perceptive Advisors LlcMajor ShareholderBuy54,652$6.49$354,691.48 12/21/2023Perceptive Advisors LlcMajor ShareholderBuy200,000$6.17$1,234,000.00 12/18/2023Perceptive Advisors LlcMajor ShareholderBuy456,923$5.41$2,471,953.43 12/15/2023Perceptive Advisors LlcMajor ShareholderBuy500,000$5.97$2,985,000.00 11/14/2023Joe BonaccorsoInsiderSell21,580$2.93$63,229.40 7/24/2023Christopher G HayesInsiderSell33,789$4.83$163,200.87 7/24/2023Paul B ManningDirectorBuy200,000$5.02$1,004,000.00 7/24/2023Ted WhiteCEOSell50,677$4.83$244,769.91 (Data available from 1/1/2013 forward) VRCA Insider Trading Activity - Frequently Asked Questions Who is on Verrica Pharmaceuticals's Insider Roster? The list of insiders at Verrica Pharmaceuticals includes A Brian Davis, Christopher G Hayes, Joe Bonaccorso, John A Stalfort III, Paul B Manning, Perceptive Advisors Llc, and Ted White. Learn more on insiders at VRCA. What percentage of Verrica Pharmaceuticals stock is owned by insiders? 42.60% of Verrica Pharmaceuticals stock is owned by insiders. Learn more on VRCA's insider holdings. Which Verrica Pharmaceuticals insiders have been buying company stock? The following insiders have purchased VRCA shares in the last 24 months: Christopher G Hayes ($37,499.40), John A Stalfort III ($499,999.50), Paul B Manning ($1,004,000.00), Perceptive Advisors Llc ($10,938,545.29), and Ted White ($49,998.90). How much insider buying is happening at Verrica Pharmaceuticals? Insiders have purchased a total of 3,241,380 VRCA shares in the last 24 months for a total of $12,530,043.09 bought. Which Verrica Pharmaceuticals insiders have been selling company stock? The following insiders have sold VRCA shares in the last 24 months: Christopher G Hayes ($163,200.87), Joe Bonaccorso ($63,229.40), and Ted White ($244,769.91). How much insider selling is happening at Verrica Pharmaceuticals? Insiders have sold a total of 106,046 Verrica Pharmaceuticals shares in the last 24 months for a total of $471,200.18 sold. More Insider Trading Tools from MarketBeat Related Companies: XOMA Insider Selling ENTA Insider Selling CRMD Insider Selling ERAS Insider Selling EPIX Insider Selling ORGO Insider Selling AVIR Insider Selling NLTX Insider Selling VNDA Insider Selling INZY Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NASDAQ:VRCA) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersNo experience to confident trader, meet my student…Wealth Builders InstituteBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressRevealed: The Unknown Biotech Powering AI in HealthcareBehind the MarketsOil Surge Predicted... But Are You ReadyThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceControversial CEO explains new way to amass wealthStansberry ResearchThe 2024 crypto bull run has already started — don’t get left behindInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verrica Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
